🔗 Permalink

Inventor profile of:

William J. Curatolo

City:

Niantic, Connecticut

Country:

United States

Published Applications:

Last publication date:

2015-07-09

Top Assignees for applications by William J. Curatolo

The entities that hold a legal rights for patent applications filed by inventor Curatolo William J.:

BEND RESEARCH, INC. 21 Bend, OR United States
PFIZER INC. 3 New York, NY United States
PFIZER INC. 1 Groton, CT United States

Recent patent applications by Curatolo William J.

William J. Curatolo from Niantic, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-07-09

US20150190518A1

Human necessities

Pharmaceutical compositions providing enhanced drug concentrations

#2 | 2015-01-22

US20150024054A1

Human necessities

SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY

#3 | 2014-10-30

US20140322325A1

Human necessities

Pharmaceutical compositions providing enhanced drug concentrations

#4 | 2013-12-26

US20130345236A1

Human necessities

Pharmaceutical compositions providing enhanced drug concentrations

#5 | 2013-08-29

US20130224301A1

Human necessities

SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY

#6 | 2012-12-27

US20120328679A1

Human necessities

Solid pharmaceutical dispersions with enhanced bioavailability

#7 | 2012-11-22

US20120295988A1

Human necessities

Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers

#8 | 2012-11-22

US20120292797A1

Human necessities

Solid pharmaceutical dispersions with enhanced bioavailability

#9 | 2012-11-15

US20120288542A1

Human necessities

Solid pharmaceutical dispersions with enhanced bioavailability

#10 | 2012-11-01

US20120277315A1

Human necessities

Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors

#11 | 2012-10-11

US20120259022A1

Human necessities

Pharmaceutical compositions providing enhanced drug concentrations

#12 | 2012-09-11

US9770562

Solid pharmaceutical dispersions with enhanced bioavailability

#13 | 2012-09-04

US10458840

Solid pharmaceutical dispersions with enhanced bioavailability

#14 | 2011-12-01

US20110294902A1

Human necessities

Pharmaceutical compositions providing enhanced drug concentrations

#15 | 2011-09-27

US9742785

Pharmaceutical compositions providing enhanced drug concentrations

#16 | 2011-07-28

US20110182947A1

Human necessities

Hydrogel-driven drug dosage form

#17 | 2011-02-15

US10176462

Pharmaceutical compositions comprising drug and concentration-enhancing polymers

#18 | 2009-06-23

US10799536

Controlled release by extrusion of solid amorphous dispersions of drugs

#19 | 2009-01-08

US20090011024A1

Human necessities

Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers

#20 | 2008-08-21

US20080199527A1

Human necessities

Enteric Coated Azithromycin Multiparticulates

#21 | 2007-12-06

US20070282009A1

Human necessities

Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors

#22 | 2007-06-26

US10066091

Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors

#23 | 2007-04-19

US20070087057A1

Human necessities

Hydrogel-Driven Drug Dosage Form

#24 | 2006-10-03

US9918127

Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors

#25 | 2006-09-21

US20060211654A1

Human necessities

Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor

#26 | 2006-09-19

US9803628

Controlled-release dosage forms of azithromycin

#27 | 2005-05-31

US9745096

Hydrogel-driven layered drug dosage form

#28 | 2005-03-03

US20050049223A1

Human necessities

Basic drug compositions with enhanced bioavailability

#29 | 2005-02-17

US20050038007A1

Human necessities

Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors

#30 | 2005-01-20

US20050013835A1

Human necessities

Stable non-dihydrate azithromycin oral suspensions

InventorID:

413982 ⎘